View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsDSM-Firmenich 배당 및 자사주 매입배당 기준 점검 0/6DSM-Firmenich 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률6.4%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향96%최근 배당 및 자사주 매입 업데이트공시 • Feb 18DSM Firmenich Announces Intention Pay Final Gross DividendDSM Firmenich announced intention to pay a gross dividend of EUR 423 million, which will be almost EUR 1.6 per share as a sort of final dividend.Upcoming Dividend • May 05Upcoming dividend of €1.70 per shareEligible shareholders must have bought the stock before 12 May 2022. Payment date: 01 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.0%).Upcoming Dividend • May 03Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 10 May 2021. Payment date: 03 June 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).모든 업데이트 보기Recent updatesRecent Insider Transactions • Apr 05Key Executive recently sold €438k worth of stockOn the 31st of March, Dimitri de Vreeze sold around 4k shares on-market at roughly €106 per share. This transaction amounted to 3.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Dimitri's only on-market trade for the last 12 months.Reported Earnings • Feb 20Full year 2022 earnings released: EPS: €2.63 (vs €6.25 in FY 2021)Full year 2022 results: EPS: €2.63 (down from €6.25 in FY 2021). Revenue: €8.39b (down 8.8% from FY 2021). Net income: €454.0m (down 58% from FY 2021). Profit margin: 5.4% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 1.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.공시 • Feb 18DSM Firmenich Announces Intention Pay Final Gross DividendDSM Firmenich announced intention to pay a gross dividend of EUR 423 million, which will be almost EUR 1.6 per share as a sort of final dividend.Recent Insider Transactions • Nov 16Key Executive recently bought €587k worth of stockOn the 7th of November, Thomas Leysen bought around 5k shares on-market at roughly €117 per share. This transaction amounted to 99% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Thomas' only on-market trade for the last 12 months.공시 • Nov 01Koninklijke DSM N.V. to Report Fiscal Year 2022 Results on Feb 16, 2023Koninklijke DSM N.V. announced that they will report fiscal year 2022 results on Feb 16, 2023Reported Earnings • Aug 03First half 2022 earnings released: EPS: €1.68 (vs €2.41 in 1H 2021)First half 2022 results: EPS: €1.68 (down from €2.41 in 1H 2021). Revenue: €4.12b (down 8.3% from 1H 2021). Net income: €290.0m (down 30% from 1H 2021). Profit margin: 7.0% (down from 9.3% in 1H 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 4.6%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 12% per year.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to €159, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 62% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €141 per share.Upcoming Dividend • May 05Upcoming dividend of €1.70 per shareEligible shareholders must have bought the stock before 12 May 2022. Payment date: 01 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.0%).Executive Departure • May 12Independent Deputy Chairwoman of Supervisory Board has left the companyOn the 6th of May, Pauline Francoise van der Meer Mohr's tenure as Independent Deputy Chairwoman of Supervisory Board ended after 10.0 years in the role. As of December 2020, Pauline Francoise personally held 1.53k shares (€219k worth at the time). A total of 4 executives have left over the last 12 months.Executive Departure • May 12Independent Chairman of Supervisory Board Robert Routs has left the companyOn the 6th of May, Robert Routs' tenure as Independent Chairman of Supervisory Board ended after 10.0 years in the role. We don't have any record of a personal shareholding under Robert's name. A total of 4 executives have left over the last 12 months.Upcoming Dividend • May 03Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 10 May 2021. Payment date: 03 June 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).Recent Insider Transactions • Apr 04Key Executive recently sold €750k worth of stockOn the 31st of March, Dimitri de Vreeze sold around 16k shares on-market at roughly €46.49 per share. This was the largest sale by an insider in the last 3 months. Dimitri has been a seller over the last 12 months, reducing personal holdings by €1.0m.Reported Earnings • Feb 20Full year 2020 earnings released: EPS €2.64 (vs €4.27 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €8.11b (down 10.0% from FY 2019). Net income: €452.0m (down 40% from FY 2019). Profit margin: 5.6% (down from 8.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Feb 20Revenue misses expectationsRevenue missed analyst estimates by 4.2%. Over the next year, revenue is forecast to grow 7.4%, compared to a 5.2% growth forecast for the Chemicals industry in Germany.Is New 90 Day High Low • Feb 04New 90-day high: €149The company is up 1.0% from its price of €147 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €120 per share.Is New 90 Day High Low • Sep 30New 90-day high: €141The company is up 13% from its price of €125 on 02 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €70.41 per share.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 DSM2 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: DSM2 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장DSM-Firmenich 배당 수익률 vs 시장DSM2의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (DSM2)n/a시장 하위 25% ()0%시장 상위 25% ()0%업계 평균 (Chemicals)0%분석가 예측 (DSM2) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 DSM2 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 DSM2 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: DSM2 German 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: 배당금 지급이 현금 흐름에 의해 충당되는지 판단하기 위해 DSM2 의 현금 지급 비율을 계산하기에는 데이터가 부족합니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석종가수익연간 수익데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스DSM-Firmenich AG는 40명의 분석가가 다루고 있습니다. 이 중 9명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jennifer BarkerBarclaysAlexander SloaneBarclaysSebastian BrayBerenberg37명의 분석가 더 보기
공시 • Feb 18DSM Firmenich Announces Intention Pay Final Gross DividendDSM Firmenich announced intention to pay a gross dividend of EUR 423 million, which will be almost EUR 1.6 per share as a sort of final dividend.
Upcoming Dividend • May 05Upcoming dividend of €1.70 per shareEligible shareholders must have bought the stock before 12 May 2022. Payment date: 01 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.0%).
Upcoming Dividend • May 03Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 10 May 2021. Payment date: 03 June 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).
Recent Insider Transactions • Apr 05Key Executive recently sold €438k worth of stockOn the 31st of March, Dimitri de Vreeze sold around 4k shares on-market at roughly €106 per share. This transaction amounted to 3.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Dimitri's only on-market trade for the last 12 months.
Reported Earnings • Feb 20Full year 2022 earnings released: EPS: €2.63 (vs €6.25 in FY 2021)Full year 2022 results: EPS: €2.63 (down from €6.25 in FY 2021). Revenue: €8.39b (down 8.8% from FY 2021). Net income: €454.0m (down 58% from FY 2021). Profit margin: 5.4% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 1.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
공시 • Feb 18DSM Firmenich Announces Intention Pay Final Gross DividendDSM Firmenich announced intention to pay a gross dividend of EUR 423 million, which will be almost EUR 1.6 per share as a sort of final dividend.
Recent Insider Transactions • Nov 16Key Executive recently bought €587k worth of stockOn the 7th of November, Thomas Leysen bought around 5k shares on-market at roughly €117 per share. This transaction amounted to 99% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Thomas' only on-market trade for the last 12 months.
공시 • Nov 01Koninklijke DSM N.V. to Report Fiscal Year 2022 Results on Feb 16, 2023Koninklijke DSM N.V. announced that they will report fiscal year 2022 results on Feb 16, 2023
Reported Earnings • Aug 03First half 2022 earnings released: EPS: €1.68 (vs €2.41 in 1H 2021)First half 2022 results: EPS: €1.68 (down from €2.41 in 1H 2021). Revenue: €4.12b (down 8.3% from 1H 2021). Net income: €290.0m (down 30% from 1H 2021). Profit margin: 7.0% (down from 9.3% in 1H 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 4.6%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 12% per year.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to €159, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 62% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €141 per share.
Upcoming Dividend • May 05Upcoming dividend of €1.70 per shareEligible shareholders must have bought the stock before 12 May 2022. Payment date: 01 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.0%).
Executive Departure • May 12Independent Deputy Chairwoman of Supervisory Board has left the companyOn the 6th of May, Pauline Francoise van der Meer Mohr's tenure as Independent Deputy Chairwoman of Supervisory Board ended after 10.0 years in the role. As of December 2020, Pauline Francoise personally held 1.53k shares (€219k worth at the time). A total of 4 executives have left over the last 12 months.
Executive Departure • May 12Independent Chairman of Supervisory Board Robert Routs has left the companyOn the 6th of May, Robert Routs' tenure as Independent Chairman of Supervisory Board ended after 10.0 years in the role. We don't have any record of a personal shareholding under Robert's name. A total of 4 executives have left over the last 12 months.
Upcoming Dividend • May 03Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 10 May 2021. Payment date: 03 June 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).
Recent Insider Transactions • Apr 04Key Executive recently sold €750k worth of stockOn the 31st of March, Dimitri de Vreeze sold around 16k shares on-market at roughly €46.49 per share. This was the largest sale by an insider in the last 3 months. Dimitri has been a seller over the last 12 months, reducing personal holdings by €1.0m.
Reported Earnings • Feb 20Full year 2020 earnings released: EPS €2.64 (vs €4.27 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €8.11b (down 10.0% from FY 2019). Net income: €452.0m (down 40% from FY 2019). Profit margin: 5.6% (down from 8.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Feb 20Revenue misses expectationsRevenue missed analyst estimates by 4.2%. Over the next year, revenue is forecast to grow 7.4%, compared to a 5.2% growth forecast for the Chemicals industry in Germany.
Is New 90 Day High Low • Feb 04New 90-day high: €149The company is up 1.0% from its price of €147 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €120 per share.
Is New 90 Day High Low • Sep 30New 90-day high: €141The company is up 13% from its price of €125 on 02 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €70.41 per share.